JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two live case ...

You have likely heard of variable valve timing by one of the names manufacturers have for the system, such as VVT-i or VTEC.

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

Traditional operative risk calculators, such as the European System for Cardiac Operative Risk Evaluation II (EuroSCORE II), ...

The MiRus Siegel™ Valve was featured in three podium presentations at the NY Valves meeting last week. Pradeep K. Yadav MD, ...

About this study The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, ...

Sometimes screening tests make a great deal of sense; other times they don’t. It all depends on how likely it is that a ...

Background On echocardiography approximately one-third of patients with severe aortic valve stenosis based on aortic valve area (AVA<1.0 cm2) demonstrate a non-severe mean pressure gradient (ΔPm; ≤40 ...

Fred Hoiberg was in the best shape of his life. No symptoms. But a silent aneurysm was ready to kill him. What happened next ...

In a world defined by macroeconomic uncertainty and shifting geopolitical realities, Pella continues to find opportunities.

In a world defined by macroeconomic uncertainty and shifting geopolitical realities, Pella continues to find opportunities.

There is currently no way to stop calcification of the aortic valve. If all else fails, the valve must be replaced. To better understand the ...